Revaree Plus for vaginal dryness in breast cancer survivors
Part of Cancer, Skin clinical trials.
This trial tests a vaginal insert called Revaree Plus to see if it helps breast cancer survivors who have vaginal dryness or pain from hormone therapy. It may be a good option if you are on an aromatase inhibitor or tamoxifen and have discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with stage 0–3 hormone-receptor positive breast cancer.
- You have finished your main cancer treatments (surgery, chemo, radiation) or are on maintenance therapy, and your cancer is currently not active.
- You are currently taking an aromatase inhibitor (like anastrozole, letrozole, or exemestane) or tamoxifen.
- You are bothered by vaginal dryness, pain with intercourse, or discomfort during a pelvic exam.
- You have not had any other cancer (except non-melanoma skin cancer).
- You are willing to stop using any vaginal estrogen products or nonhormonal moisturizers for 4 weeks before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a gentle radiofrequency treatment can help breast cancer patients with vaginal dryness that hasn't improved with standard moisturizers. It aims to improve comfort and quality of life.
This study examines vaginal dryness and discomfort—common side effects of breast cancer treatment—in women who've survived the disease. Researchers want to understand how often this happens and how much it affects daily life, which may help doctors better support survivors.
This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.
This trial tests a non-surgical radiofrequency treatment, combined with pelvic floor exercises, to help with vaginal dryness and other menopause symptoms in breast cancer survivors. It may be an option if you are free of cancer and have bothersome vaginal dryness.
This study looks at ways to prevent and treat sexual discomfort in people with hormone-receptor positive breast cancer. It targets women who are not having current vaginal dryness or pain related to lower estrogen, and may help protect sexual comfort during cancer-related hormone treatment.
This study compares a vaginal estradiol tablet (Vagifem) to a moisturizer to see which works better for treating vaginal dryness, irritation, and related urinary symptoms in women living with HIV who have gone through menopause. The study also looks at how each treatment affects the healthy bacteria in the vagina.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.